ZYBT
Zhengye Biotechnology Holdin
NASDAQ · Pharmaceuticals
$0.84
+0.09 (+12.05%)
Open$0.78
Previous Close$0.75
Day High$0.90
Day Low$0.78
52W High$13.74
52W Low$10.51
Volume—
Avg Volume631.1K
Market Cap54.03M
P/E Ratio22.34
EPS$0.53
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 12.11M | 10.68M | 11.04M |
| Net Income | 2.69M | 1.92M | 1.97M |
| Profit Margin | 22.3% | 18.0% | 17.9% |
| EBITDA | 3.66M | 3.67M | 3.48M |
| Free Cash Flow | 1.61M | 1.47M | 1.80M |
| Rev Growth | -0.1% | -5.4% | +15.2% |
| Debt/Equity | 0.37 | 0.43 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |